Search

everythinglearnresearchcommunity

for

Search:↓

Ionizing radiation causes irreversible skin damage, with single doses leading to acute injury and hair graying, and fractional doses causing more severe long-term tissue damage.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

More research is needed to understand chemotherapy-induced hair loss and its phases.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

A rare case showed basal cell carcinoma and leiomyosarcoma coexisting, needing careful diagnosis and treatment.

GLI and EGF signalling affect Basal Cell Carcinoma development and could be therapeutic targets.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Immune therapy for cancer can cause hair loss scars in some patients.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Overexpressing COX-2 in mice skin reduces skin tumor development.

Non-coding RNAs could help detect and treat radiation damage.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

EGFR helps protect hair follicles from bacterial infections.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

HPV8 E6 gene causes growth of certain skin stem cells.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

Inducing survivin in normal tissues can protect against radiation damage.